Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 238 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2450 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-11-28 | 2020-01-24 | 99968 |
ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-11-28 | 2020-02-21 | 99971 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-11-28 | 2020-02-21 | 99974 |
TEVA-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-09-24 | 2020-10-30 | 124992 |
TEVA-ZOLMITRIPTAN OD | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-10-22 | 2020-11-26 | 126933 |
TEVA-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-02-18 | 2021-04-15 | 134340 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-04-29 | 2021-07-09 | 138282 |
TEVA-ZOLMITRIPTAN OD | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-09-30 | 2021-10-07 | 146472 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-03-24 | 2022-05-05 | 157265 |
ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-03-31 | 2022-06-17 | 157637 |
TEVA-ZOLMITRIPTAN OD | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Actual shortage | 2022-05-19 | 2022-12-01 | 161012 |
TEVA-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-04-28 | 169983 |
ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169990 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169995 |
TEVA-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-02-09 | 2023-04-28 | 184213 |
TEVA-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-10-05 | 2023-11-09 | 206428 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Resolved | 2019-10-17 | 2019-10-26 | 96730 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |